http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0197824-A2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_21a05dce518745106cff564dfda14fd6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2a818fe25f2e2a7129b0fdeacbf66145 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_91aa94cde1a253c3abb39fa2eb9ee5e9 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-47 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-14 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-47 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12 |
| filingDate | 2001-06-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bb0252c8ea0f942e196fba39f25f771e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b5572bd071ca9ad93a64f8dd192fddad |
| publicationDate | 2001-12-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-0197824-A2 |
| titleOfInvention | Use of phyllanthus constituents for treating or preventing infections caused by flaviviridae |
| abstract | The invention relates to the use of one or more phyllanthus constituent(s) or substances or substance mixtures obtained therefrom for preventing or treating infection diseases, which are caused by viruses of the family of Flaviviridae or which are involved in the development or progression of viruses of the family of Flaviviridae. The invention also relates to the use of one or more phyllanthus constituent(s) or substances or substance mixtures obtained therefrom for producing a medicament used in the prevention or treatment of infectious diseases, which are caused by viruses of the family of Flaviviridae or which are involved in the development or progression of viruses of the family of Flaviviridae. The invention additionally relates to the use of one or more phyllanthus constituent(s) or substances or substance mixtures obtained therefrom for inhibiting the multiplication of viruses of the family of Flaviviridae. A method is also disclosed for preventing or treating infectious diseases in a mammal, which are caused by viruses of the family of Flaviviridae or which are involved in the development or progression of viruses of the family of Flaviviridae, whereby one or more phyllanthus constituent(s) or substances or substance mixtures obtained therefrom is/are administered to the mammal. Additionally disclosed is a method for inhibiting the multiplication of viruses of the family of Flaviviridae, whereby one or more phyllanthus constituent(s) or substances or substance mixtures obtained therefrom is/are brought into contact with the viruses. A preferred virus is the hepatitis C virus. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3954379-A1 |
| priorityDate | 2000-06-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 57.